<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="publisher-id">International Journal of COPD</journal-id><journal-title-group><journal-title>International Journal of Chronic Obstructive Pulmonary Disease</journal-title></journal-title-group><issn pub-type="ppub">1176-9106</issn><issn pub-type="epub">1178-2005</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27330284</article-id><article-id pub-id-type="pmc">4898045</article-id><article-id pub-id-type="doi">10.2147/COPD.S91253</article-id><article-id pub-id-type="publisher-id">copd-11-1161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Can a supported self-management program for COPD upon hospital discharge reduce readmissions? A randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Johnson-Warrington</surname><given-names>Vicki</given-names></name><xref ref-type="aff" rid="af1-copd-11-1161">1</xref><xref ref-type="aff" rid="af2-copd-11-1161">2</xref></contrib><contrib contrib-type="author"><name><surname>Rees</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="af3-copd-11-1161">3</xref></contrib><contrib contrib-type="author"><name><surname>Gelder</surname><given-names>Colin</given-names></name><xref ref-type="aff" rid="af1-copd-11-1161">1</xref></contrib><contrib contrib-type="author"><name><surname>Morgan</surname><given-names>Mike D</given-names></name><xref ref-type="aff" rid="af4-copd-11-1161">4</xref></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Sally J</given-names></name><xref ref-type="aff" rid="af2-copd-11-1161">2</xref><xref ref-type="aff" rid="af4-copd-11-1161">4</xref><xref ref-type="corresp" rid="c1-copd-11-1161"/></contrib></contrib-group><aff id="af1-copd-11-1161"><label>1</label>Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK</aff><aff id="af2-copd-11-1161"><label>2</label>Faculty of Health and Life Sciences, Coventry University, Coventry, UK</aff><aff id="af3-copd-11-1161"><label>3</label>Warwick Medical School, University of Warwick, Coventry, UK</aff><aff id="af4-copd-11-1161"><label>4</label>Centre for Exercise and Rehabilitation Science, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK</aff><author-notes><corresp id="c1-copd-11-1161">Correspondence: S Singh, Centre for Exercise and Rehabilitation Science, Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Groby Road, Leicester LE3 9QP, UK, Tel +44 116 258 3652, Fax +44 116 250 2743, Email <email>vicki.johnson@uhl-tr.nhs.uk</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>02</day><month>6</month><year>2016</year></pub-date><volume>11</volume><fpage>1161</fpage><lpage>1169</lpage><permissions><copyright-statement>&#x000a9; 2016 Johnson-Warrington et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2016</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Patients with COPD experience exacerbations that may require hospitalization. Patients do not always feel supported upon discharge and frequently get readmitted. A Self-management Program of Activity, Coping, and Education for COPD (SPACE for COPD), a brief self-management program, may help address this issue.</p></sec><sec><title>Objective</title><p>To investigate if SPACE for COPD employed upon hospital discharge would reduce readmission rates at 3 months, compared with usual care.</p></sec><sec><title>Methods</title><p>This is a prospective, single-blinded, two-center trial (ISRCTN84599369) with participants admitted for an exacerbation, randomized to usual care or SPACE for COPD. Measures, including health-related quality of life and exercise capacity, were taken at baseline (hospital discharge) and at 3 months. The primary outcome measure was respiratory readmission at 3 months.</p></sec><sec><title>Results</title><p>Seventy-eight patients were recruited (n=39 to both groups). No differences were found in readmission rates or mortality at 3 months between the groups. Ten control patients were readmitted within 30 days compared to five patients in the intervention group (<italic>P</italic>&#x0003e;0.05). Both groups significantly improved their exercise tolerance and Chronic Respiratory Questionnaire (CRQ-SR) results, with between-group differences approaching statistical significance for CRQ-dyspnea and CRQ-emotion, in favor of the intervention. The &#x0201c;Ready for Home&#x0201d; survey revealed that patients receiving the intervention reported feeling better able to arrange their life to cope with COPD, knew when to seek help about feeling unwell, and more often took their medications as prescribed, compared to usual care (<italic>P</italic>&#x0003c;0.05).</p></sec><sec><title>Conclusion</title><p>SPACE for COPD did not reduce readmission rates at 3 months above that of usual care. However, encouraging results were seen in secondary outcomes for those receiving the intervention. Importantly, SPACE for COPD appears to be safe and may help prevent readmission with 30 days.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>COPD exacerbations</kwd><kwd>pulmonary rehabilitation</kwd><kwd>exercise</kwd><kwd>emphysema</kwd><kwd>self-management</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Patients with COPD experience exacerbations, some of which require hospitalization,<xref rid="b1-copd-11-1161" ref-type="bibr">1</xref> which accounts for a significant proportion of the &#x000a3;810&#x02013;930 million economic cost annually<xref rid="b2-copd-11-1161" ref-type="bibr">2</xref> in the United Kingdom. Furthermore, exacerbations and admissions are associated with reduced physical functioning,<xref rid="b3-copd-11-1161" ref-type="bibr">3</xref>,<xref rid="b4-copd-11-1161" ref-type="bibr">4</xref> which may contribute to the increased readmission risk.<xref rid="b5-copd-11-1161" ref-type="bibr">5</xref> The 28-day readmission rates ar&#x000ea;33%,<xref rid="b2-copd-11-1161" ref-type="bibr">2</xref> and hospitals are penalized financially if patients get readmitted within 30 days of discharge.<xref rid="b6-copd-11-1161" ref-type="bibr">6</xref></p><p>A patient survey<xref rid="b6-copd-11-1161" ref-type="bibr">6</xref> highlighted that individuals do not always feel able to cope at home postexacerbation. Additionally, patients report that they want more information and advice on practical coping issues,<xref rid="b6-copd-11-1161" ref-type="bibr">6</xref> highlighting the need for supportive interventions.</p><p>Pulmonary rehabilitation (PR) is one intervention that has increasingly been employed to address the reduced exercise capacity associated with exacerbations.<xref rid="b7-copd-11-1161" ref-type="bibr">7</xref>,<xref rid="b8-copd-11-1161" ref-type="bibr">8</xref> PR consists of exercise and education to promote health-enhancing behaviors.<xref rid="b9-copd-11-1161" ref-type="bibr">9</xref> Rehabilitation offered early after hospital discharge can reduce readmission rates and improve exercise capacity,<xref rid="b7-copd-11-1161" ref-type="bibr">7</xref> but other studies have shown that it is difficult to recruit patients,<xref rid="b8-copd-11-1161" ref-type="bibr">8</xref> indicating that it may not be wholly acceptable during this period. Furthermore, no improvements in readmission rates or physical function were observed for an early intensive rehabilitation intervention over a longer, 12-month period,<xref rid="b10-copd-11-1161" ref-type="bibr">10</xref> highlighting the need for a different approach.</p><p>With finite health care resources, it is important to prevent unnecessary hospital admissions. Given the detrimental physical and emotional effects of hospitalization, it is important to devise an intervention to help reduce the associated impacts, while being safe and acceptable to patients.</p><p>Recent attention has been given to self-management interventions, from simple exacerbation management plans to comprehensive behavior-changing programs.<xref rid="b11-copd-11-1161" ref-type="bibr">11</xref> However, there have been concerns with these types of interventions, particularly after an acute exacerbation, as recent studies have observed increased mortality rates within the intervention arms.<xref rid="b10-copd-11-1161" ref-type="bibr">10</xref>,<xref rid="b12-copd-11-1161" ref-type="bibr">12</xref> Although reasons for this have not been established, it has been postulated that patients may have misplaced confidence in their self-management skills.</p><p>A Self-management Program of Activity, Coping, and Education<xref rid="b13-copd-11-1161" ref-type="bibr">13</xref> for COPD (SPACE for COPD) improves clinical and health care utilization outcomes within a stable COPD population<xref rid="b14-copd-11-1161" ref-type="bibr">14</xref> but has not been investigated as a stand-alone intervention within an acute setting. SPACE for COPD is a brief intervention containing practical advice, a home-based exercise program, and an exacerbation action plan that aims to support patients to manage their day-to-day activities and promote health-enhancing behaviors.</p><p>Our hypothesis was that a structured self-management strategy (SPACE for COPD) employed upon hospital discharge would reduce readmissions for patients with COPD, compared to usual care. We also investigated the effect of SPACE for COPD on exercise tolerance, psychological impact, health-related quality of life, and disease knowledge.</p></sec><sec sec-type="methods"><title>Methods</title><sec sec-type="methods"><title>Design</title><p>A prospective, two-center, single-blinded randomized controlled trial was conducted during January 2013&#x02013;September 2014. Participants provided written informed consent, and ethical approval was granted by National Research Ethics Service Committee West Midlands &#x02013; Solihull, reference 12/WM/0106, trial registration ISRCTN84599369.</p></sec><sec><title>Population</title><p>Participants were recruited from University Hospitals Coventry and Warwickshire and University Hospitals of Leicester NHS Trusts. Participants were included if they had an established diagnosis of COPD and grade 2&#x02013;5 dyspnea according to the Medical Research Council. Individuals were excluded if their reason for admission was not an acute exacerbation of COPD or if they were 1) unable to safely participate in unsupervised exercise (ie, due to psychiatric, locomotive, cardiac, or neurological impairments), 2) involved in other research, 3) unable to read English, 4) had previously received SPACE for COPD or completed PR within the previous 6 months, or 5) had four or more admissions in the previous 12 months.</p></sec><sec><title>Randomization</title><p>Participants were randomized to receive usual care or SPACE for COPD via a web-based, concealed allocation program (<ext-link ext-link-type="uri" xlink:href="http://www.sealedenvelope.com">www.sealedenvelope.com</ext-link>) using simple random permuted block 1:1 randomization by VJ-W. Randomization was performed after the participants completed the baseline assessment, with treatment allocation prior to hospital discharge.</p></sec><sec><title>Usual care</title><p>All participants received usual care during the study period. This consisted of a follow-up appointment with the community COPD team or telephone follow-up after an inpatient review by a respiratory nurse specialist and an outpatient consultant review. Due to waiting times, participants did not receive PR during the study period.</p></sec><sec><title>SPACE for COPD</title><p>SPACE for COPD has previously been described;<xref rid="b13-copd-11-1161" ref-type="bibr">13</xref> briefly, it comprises written educational information and a home-based exercise program (consisting of a daily walking-based aerobic program and thrice weekly resistance training using free weights of the upper and lower limbs). Participants were introduced to the manual and exercises by a trained physiotherapist (VJ-W) in a one-to-one session lasting 30&#x02013;45 minutes, using motivational interviewing techniques to facilitate behavior change, goal setting, and problem solving. Participants were advised how to progress and that the manual could be valuable for the future to reinforce any life-long lifestyle changes. Participants received structured phone calls within 72 hours and at 2 weeks, 4 weeks, 6 weeks, 8 weeks, and 10 weeks from hospital discharge with the aim of reinforcing skills, helping identify and manage exacerbations, promoting an active lifestyle, and providing encouragement, while tailoring to patient needs. If participants get readmitted during the 3-month follow-up period, they continued the intervention as planned.</p></sec><sec><title>Outcome measures</title><p>The primary prespecified outcome measure was respiratory-related hospital readmission at 3 months. Secondary outcomes were the Chronic Respiratory Questionnaire &#x02013; self reported (CRQ-SR),<xref rid="b15-copd-11-1161" ref-type="bibr">15</xref> Hospital Anxiety and Depression Score,<xref rid="b16-copd-11-1161" ref-type="bibr">16</xref> Bristol COPD Knowledge Questionnaire,<xref rid="b17-copd-11-1161" ref-type="bibr">17</xref> Incremental Shuttle Walk Test (ISWT),<xref rid="b18-copd-11-1161" ref-type="bibr">18</xref> Endurance Shuttle Walking Test (ESWT),<xref rid="b19-copd-11-1161" ref-type="bibr">19</xref> Pulmonary Rehabilitation Adapted Index of Self-Efficacy,<xref rid="b20-copd-11-1161" ref-type="bibr">20</xref> and the &#x0201c;Ready for Home&#x0201d; survey.<xref rid="b6-copd-11-1161" ref-type="bibr">6</xref> All outcomes were measured at baseline (during admission but as close to discharge as possible) and 3 months after randomization, by a clinician blinded to treatment allocation. Mortality and readmission data were collected from hospital and primary care databases.</p></sec><sec><title>Sample size</title><p>Based on the primary outcome measure of readmission at 3 months, 36 participants were required in each arm to detect a fall in readmissions comparable to Seymour et al.<xref rid="b21-copd-11-1161" ref-type="bibr">21</xref> Calculations were based on 5% significance (alpha 0.05), 80% power, and two-tailed test using the SAS system.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Data were tested for normality and appropriate parametric or nonparametric tests used. For binary variables (including primary outcome measure), Fisher&#x02019;s exact test was used to compare differences between the two groups. Odds ratios were calculated for 30-day readmissions. Independent <italic>t</italic>-tests or Kruskal&#x02013;Wallis tests were used to compare between-group differences. Paired <italic>t</italic>-tests or Wilcoxon signed rank tests were used to compare within-group changes. Statistical significance was accepted if <italic>P</italic>&#x0003c;0.05. Analysis was conducted on an intention-to-treat basis. Number (and percentages) of those achieving the known minimal clinically important differences of 0.5 for CRQ-SR,<xref rid="b22-copd-11-1161" ref-type="bibr">22</xref> &#x02212;1.5 for Hospital Anxiety and Depression Score,<xref rid="b23-copd-11-1161" ref-type="bibr">23</xref> 47.5 m for ISWT,<xref rid="b24-copd-11-1161" ref-type="bibr">24</xref> and 186 seconds for ESWT<xref rid="b25-copd-11-1161" ref-type="bibr">25</xref> was calculated.</p></sec><sec><title>Protocol changes</title><p>Ethical approval was granted to reduce the time given to participants to consider study participation from 24 hours to whenever they felt they fully understood. This was to allow the inclusion of patients with a short hospital stay (ie, those with mild COPD exacerbations) or those discharged over a weekend.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The consort diagram (<xref ref-type="fig" rid="f1-copd-11-1161">Figure 1</xref>) describes the trial recruitment. Eighty-five patients consented, of whom 78 were randomized (39 to each arm) and included in the intention-to-treat analysis with 36 in usual care and 35 in SPACE for COPD available with follow-up data.</p><p><xref ref-type="table" rid="t1-copd-11-1161">Table 1</xref> shows the baseline characteristics. No significant differences existed in baseline measures between groups (<italic>P</italic>&#x0003e;0.05) or outcome measures between sites (<italic>P</italic>&#x0003e;0.05). Twenty-two patients used home oxygen (ten used both long-term oxygen therapy and ambulatory, eight used solely long-term oxygen therapy, two ambulatory, and two palliative oxygen) at a mean (standard deviation) flow rate of 1.52 (0.57) L.</p><sec><title>Primary outcome measure</title><p>Twenty-five patients (32.05%) were readmitted for respiratory reasons during the 3-month follow-up period: 13 receiving usual care and 12 receiving the intervention (33.33% vs 30.77%, <italic>P</italic>=0.808). <xref ref-type="fig" rid="f2-copd-11-1161">Figure 2</xref> shows the Kaplan&#x02013;Meier curves.</p></sec><sec><title>Health care utilization</title><p>Readmission data were nonnormally distributed. Thirty-one patients (14 controls and 17 receiving the intervention, <italic>P</italic>=0.488) were readmitted for any reason during the 3-month period, with 44 admissions (21 in usual care and 23 in intervention, <italic>P</italic>=0.726). Respiratory reasons accounted for 79.55% of these readmissions (19 in usual care and 16 in SPACE for COPD, <italic>P</italic>=0.674).</p><p><xref ref-type="table" rid="t2-copd-11-1161">Table 2</xref> shows the hospital length of stay for those who got readmitted. Median (interquartile range) days to first respiratory readmission was 14 (4&#x02013;39) for usual care compared to 47 (4.5&#x02013;55.5) for the intervention (<italic>P</italic>=0.341).</p><p>Ten usual care patients were readmitted within 30 days for respiratory reasons compared to five patients receiving the intervention (25.64% vs 12.82%, <italic>P</italic>=0.151), odds ratio (95% confidence interval) 0.426 (0.131&#x02013;1.391), <italic>P</italic>&#x0003e;0.05.</p><p>All participants were offered PR after the study period. Fourteen patients expressed an interest (seven in each group).</p></sec><sec><title>Mortality</title><p>Within the 3-month study period, three usual care patients died (all due to respiratory reasons, median 65 days to death), whereas no patients receiving SPACE for COPD died, <italic>P</italic>=0.077. Data censored on September 30, 2014 (mean 339 days to censoring), revealed that seven usual care patients and three patients receiving SPACE for COPD had died, <italic>P</italic>=0.176.</p></sec><sec><title>Serious adverse events</title><p>Only hospitalizations and mortality were reported as serious adverse events (SAEs). No other SAEs were found.</p></sec><sec sec-type="methods"><title>Exercise and questionnaire data</title><p>ISWT and ESWT were nonnormally distributed. <xref ref-type="table" rid="t3-copd-11-1161">Table 3</xref> and <xref ref-type="fig" rid="f3-copd-11-1161">Figure 3</xref> show within- and between-group differences for quality of life, disease knowledge, exercise tolerance, and self-efficacy. Within-group changes (<italic>P</italic>&#x0003c;0.05) were seen for both groups for all CRQ-SR domains except emotion for usual care (<italic>P</italic>=0.216). Between-group differences approached statistical significance for CRQ-dyspnea (<italic>P</italic>=0.062) and -emotion (<italic>P</italic>=0.077) domains, in favor of the intervention. Both groups significantly increased their exercise tolerance (<italic>P</italic>&#x0003c;0.05). Disease-specific knowledge increased from baseline for those who received SPACE for COPD (<italic>P</italic>&#x0003c;0.05) but not for usual care. <xref ref-type="table" rid="t4-copd-11-1161">Table 4</xref> shows that more patients who received the intervention achieved the minimal clinically important difference for CRQ-dyspnea (<italic>P</italic>=0.039).</p><p>At 3 months, <xref ref-type="table" rid="t5-copd-11-1161">Table 5</xref> shows how people felt upon their (initial) discharge from hospital from the Ready for Home survey. More patients following SPACE for COPD felt confident that medications could help and were reassured that good support was available at home compared to usual care (<italic>P</italic>&#x0003c;0.05). <xref ref-type="table" rid="t6-copd-11-1161">Table 6</xref> shows that more patients in the SPACE for COPD arm felt that they were better able to arrange their life to cope with COPD, knew when to seek help about feeling unwell, and more often took their medications on time as prescribed, compared to usual care (all <italic>P</italic>&#x0003c;0.05).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The supported self-management program, SPACE for COPD, delivered at the time of an acute exacerbation, did not reduce respiratory-related hospital readmissions at 3 months. However, benefits in quality of care and potential improvements in health-related quality of life, delaying time to first readmission, and reducing hospital length of stay were observed for those receiving the intervention. We did not find an increased mortality rate, and thus, SPACE for COPD appears a safe intervention in this population.</p><p>Within-group changes were observed for most outcomes for both groups. This gives further support that patients, after an acute exacerbation requiring hospitalization, experience a period of natural recovery.<xref rid="b10-copd-11-1161" ref-type="bibr">10</xref> There were encouraging trends for improved outcomes in those receiving SPACE for COPD compared to those receiving usual care, especially for CRQ-SR (with dyspnea and emotion scores improving by more than double for those receiving the intervention compared to usual care) and time to first readmission, although many did not reach statistical significance. This is likely due to the relatively small number of participants, so these secondary outcomes are likely to be underpowered.</p><p>Although not statistically significant, there were more admissions within the 30-day postdischarge period for respiratory reasons (attracting financial penalties of ~&#x000a3;2,000<xref rid="b26-copd-11-1161" ref-type="bibr">26</xref> each) in the group receiving usual care compared to the self-management group. Therefore, SPACE for COPD may be a feasible, brief intervention implementable immediately upon hospital discharge to help reduce this financial consequence and provide some benefits in quality of life and emotional support. Patients could then attend more intensive interventions when stable and natural recovery has plateaued, such as outpatient PR, which has established health and economic benefits.<xref rid="b27-copd-11-1161" ref-type="bibr">27</xref> However, we found that only 14 participants expressed an interest in attending PR. Furthermore, 164 patients declined to take part in this study. Reasons for this varied mainly from none being given to having done similar previous research or PR before, preferring to wait for PR, feeling &#x0201c;too old&#x0201d; or not well enough.</p><p>Previous studies<xref rid="b10-copd-11-1161" ref-type="bibr">10</xref>,<xref rid="b12-copd-11-1161" ref-type="bibr">12</xref> have found an increased mortality rate in self-management interventions, which, although not fully understood, has caused safety concerns in delivering these types of interventions. We did not show an increased mortality rate (nor other SAEs) for those who received SPACE for COPD, compared to usual care; therefore, this particular intervention appears to be safe, at least in the short term. Previous authors<xref rid="b10-copd-11-1161" ref-type="bibr">10</xref> reasoned that their observed increased mortality rates could be due to either chance, failure to intervene or alterations in health behavior, which delay patients seeking medical advice. In our study, patients who received the self-management program reported that they better knew when to seek medical advice when feeling unwell, suggesting that they would not delay seeking advice. Furthermore, patients receiving SPACE for COPD also reported more often taking their medications on time as prescribed. These are positive behavior change perceptions; however, this did not translate into preventing readmissions.</p><p>Limitations to this study include recruitment constraints. Due to available resources, there was not complete coverage to recruit during peak admission periods on both sites. In addition, some inpatient stays were so brief that being able to perform all research procedures within a busy, acute clinical setting was difficult.</p><p>This study, along with others, has shown that it can be difficult to prevent hospital readmission in a sick population. To take on board all information during a relatively short introduction to our self-management program, while patients are unwell and may have impaired cognition,<xref rid="b28-copd-11-1161" ref-type="bibr">28</xref> may have contributed to the limited effectiveness of this intervention. Furthermore, all participants received specialist, usual care follow-up, and so their care could already be optimum. However, SPACE for COPD may help increase patient&#x02019;s self-management ability and confidence in the short term as displayed by the delay in time to readmission. It may be unreasonable to expect a reduction in readmission rates and arguably should not be seen as a negative outcome for the trial; it may be more realistic to anticipate a change in other aspects of successful disease management, for example, health-related quality of life. Analyses of qualitative interviews and health economic data may provide further insight into this and participants&#x02019; compliance and adherence to the intervention.</p></sec><sec><title>Conclusion</title><p>In conclusion, we found that SPACE for COPD, delivered upon hospital discharge and supported postdischarge, did not reduce readmission rate at 3 months compared to usual care alone. However, we did find that this supported self-management intervention provided some potential benefits in health-related quality of life and delaying time to first readmission, which appears safe, as additional mortality was not incurred, in contrast to findings from other recent studies.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the British Lung Foundation for funding, Dr Matthew Richardson for statistical advice, and Leicestershire, Northamptonshire, and Rutland and West Midlands (South) Comprehensive Local Research Networks for screening.</p><p>Presented as an oral presentation in mini symposium B16 at the American Thoracic Society 18th May 2015 &#x02013; A Supported Self-Management Programme for Chronic Obstructive Pulmonary Disease (COPD) Upon Hospital Discharge: A Randomized Controlled Trial.</p><p>British Lung Foundation grant RB11-2.</p></ack><fn-group><fn><p><bold>Author contributions</bold></p><p>All authors contributed toward data analysis, drafting and critically revising the paper and agree to be accountable for all aspects of the work. SJS and KR were supported by the Collaboration for Leadership in Applied Health Research and Care, East and West Midlands, respectively and the NIHR Leicester Respiratory Biomedical Research Unit (BRU). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.</p></fn><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-copd-11-1161"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Institute for Health and Clinical Excellence</collab></person-group><source>Chronic Obstructive Pulmonary Disease Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care (Partial Update)</source><publisher-loc>London</publisher-loc><publisher-name>National Institute for Health and Clinical Excellence</publisher-name><year>2010</year></element-citation></ref><ref id="b2-copd-11-1161"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Department of Health</collab></person-group><source>Consultation on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD) in England</source><publisher-loc>London</publisher-loc><publisher-name>Department of Health</publisher-name><year>2010</year></element-citation></ref><ref id="b3-copd-11-1161"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitta</surname><given-names>F</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Probst</surname><given-names>VS</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name></person-group><article-title>Physical activity and hospitalization for exacerbation of COPD</article-title><source>Chest</source><year>2006</year><volume>129</volume><issue>3</issue><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">16537849</pub-id></element-citation></ref><ref id="b4-copd-11-1161"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><etal/></person-group><article-title>Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I</article-title><source>Thorax</source><year>2003</year><volume>58</volume><issue>9</issue><fpage>752</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">12947130</pub-id></element-citation></ref><ref id="b5-copd-11-1161"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Aymerich</surname><given-names>J</given-names></name><name><surname>Farrero</surname><given-names>E</given-names></name><name><surname>Felez</surname><given-names>MA</given-names></name><etal/><collab>Estudi del Factors de Risc d&#x02019;Aguditzaci&#x000f3; de la MPOC investigators</collab></person-group><article-title>Risk factors of readmission to hospital for a COPD exacerbation: a prospective study</article-title><source>Thorax</source><year>2003</year><volume>58</volume><issue>2</issue><fpage>100</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">12554887</pub-id></element-citation></ref><ref id="b6-copd-11-1161"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>British Lung Foundation and British Thoracic Society</collab></person-group><source>Ready for Home? Improving Hospital Discharge Care for People Living with COPD</source><publisher-loc>London</publisher-loc><publisher-name>British Thoracic Society</publisher-name><year>2010</year></element-citation></ref><ref id="b7-copd-11-1161"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Fergusson</surname><given-names>W</given-names></name><etal/></person-group><article-title>Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study</article-title><source>Respirology</source><year>2009</year><volume>14</volume><issue>2</issue><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">19272084</pub-id></element-citation></ref><ref id="b8-copd-11-1161"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>WD</given-names></name><name><surname>Polkey</surname><given-names>MI</given-names></name><name><surname>Donaldson</surname><given-names>N</given-names></name><name><surname>Gray</surname><given-names>BJ</given-names></name><name><surname>Moxham</surname><given-names>J</given-names></name></person-group><article-title>Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study</article-title><source>BMJ</source><year>2004</year><volume>329</volume><issue>7476</issue><fpage>1209</fpage><pub-id pub-id-type="pmid">15504763</pub-id></element-citation></ref><ref id="b9-copd-11-1161"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Garvey</surname><given-names>C</given-names></name><etal/><collab>ATS/ERS Task Force on Pulmonary Rehabilitation</collab></person-group><article-title>An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>8</issue><fpage>e13</fpage><lpage>e64</lpage><pub-id pub-id-type="pmid">24127811</pub-id></element-citation></ref><ref id="b10-copd-11-1161"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greening</surname><given-names>NJ</given-names></name><name><surname>Williams</surname><given-names>JE</given-names></name><name><surname>Hussain</surname><given-names>SF</given-names></name><etal/></person-group><article-title>An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial</article-title><source>BMJ</source><year>2014</year><volume>349</volume><fpage>g4315</fpage><pub-id pub-id-type="pmid">25004917</pub-id></element-citation></ref><ref id="b11-copd-11-1161"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagg</surname><given-names>K</given-names></name></person-group><article-title>Unravelling self-management for COPD: what next?</article-title><source>Chron Respir Dis</source><year>2012</year><volume>9</volume><issue>1</issue><fpage>5</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22308549</pub-id></element-citation></ref><ref id="b12-copd-11-1161"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>V</given-names></name><name><surname>Gaziano</surname><given-names>J</given-names></name><name><surname>Lew</surname><given-names>R</given-names></name><etal/></person-group><article-title>A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized controlled trial</article-title><source>Ann Intern Med</source><year>2012</year><volume>156</volume><issue>10</issue><fpage>673</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">22586006</pub-id></element-citation></ref><ref id="b13-copd-11-1161"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apps</surname><given-names>LD</given-names></name><name><surname>Mitchell</surname><given-names>KE</given-names></name><name><surname>Harrison</surname><given-names>SL</given-names></name><etal/></person-group><article-title>The development and pilot testing of the self-management program of activity, coping and education for chronic obstructive pulmonary disease (SPACE for COPD)</article-title><source>Int J Chron Obstruct Pulmon Dis</source><year>2013</year><volume>8</volume><fpage>317</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">23874093</pub-id></element-citation></ref><ref id="b14-copd-11-1161"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>KE</given-names></name><name><surname>Johnson-Warrington</surname><given-names>V</given-names></name><name><surname>Apps</surname><given-names>LD</given-names></name><etal/></person-group><article-title>A self-management programme for COPD: a randomised controlled trial</article-title><source>Eur Respir J</source><year>2014</year><volume>44</volume><issue>6</issue><fpage>1538</fpage><lpage>1547</lpage><pub-id pub-id-type="pmid">25186259</pub-id></element-citation></ref><ref id="b15-copd-11-1161"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JE</given-names></name><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Sewell</surname><given-names>L</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name></person-group><article-title>Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR)</article-title><source>Thorax</source><year>2001</year><volume>56</volume><issue>12</issue><fpage>954</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">11713359</pub-id></element-citation></ref><ref id="b16-copd-11-1161"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zigmond</surname><given-names>AS</given-names></name><name><surname>Snaith</surname><given-names>RP</given-names></name></person-group><article-title>The hospital anxiety and depression scale</article-title><source>Acta Psychiatr Scand</source><year>1983</year><volume>67</volume><issue>6</issue><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">6880820</pub-id></element-citation></ref><ref id="b17-copd-11-1161"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>P</given-names></name><name><surname>Roberts</surname><given-names>S</given-names></name><name><surname>Kalisky</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>P</given-names></name></person-group><article-title>Bristol COPD knowledge questionnaire (BCKQ): testing what we teach patients about COPD</article-title><source>Chron Respir Dis</source><year>2006</year><volume>3</volume><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">16916006</pub-id></element-citation></ref><ref id="b18-copd-11-1161"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name><name><surname>Scott</surname><given-names>S</given-names></name><name><surname>Walters</surname><given-names>D</given-names></name><name><surname>Hardman</surname><given-names>AE</given-names></name></person-group><article-title>Development of a shuttle walking test of disability in patients with chronic airways obstruction</article-title><source>Thorax</source><year>1992</year><volume>47</volume><issue>12</issue><fpage>1019</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">1494764</pub-id></element-citation></ref><ref id="b19-copd-11-1161"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revill</surname><given-names>SM</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Hardman</surname><given-names>AE</given-names></name></person-group><article-title>The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease</article-title><source>Thorax</source><year>1999</year><volume>54</volume><issue>3</issue><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">10325896</pub-id></element-citation></ref><ref id="b20-copd-11-1161"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>E</given-names></name><name><surname>Sewell</surname><given-names>L</given-names></name><name><surname>Wagg</surname><given-names>K</given-names></name><name><surname>Deacon</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name></person-group><article-title>Measuring a change in self-efficacy following pulmonary rehabilitation: an evaluation of the PRAISE tool</article-title><source>Chest</source><year>2011</year><volume>140</volume><issue>6</issue><fpage>1534</fpage><lpage>1539</lpage><pub-id pub-id-type="pmid">21737490</pub-id></element-citation></ref><ref id="b21-copd-11-1161"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>JM</given-names></name><name><surname>Moore</surname><given-names>L</given-names></name><name><surname>Jolley</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Outpatient pulmonary rehabilitation following acute exacerbations of COPD</article-title><source>Thorax</source><year>2010</year><volume>65</volume><issue>5</issue><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">20435864</pub-id></element-citation></ref><ref id="b22-copd-11-1161"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname><given-names>R</given-names></name><name><surname>Singer</surname><given-names>J</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name></person-group><article-title>Measurement of health status. Ascertaining the minimal clinically important difference</article-title><source>Control Clin Trials</source><year>1989</year><volume>10</volume><fpage>407</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">2691207</pub-id></element-citation></ref><ref id="b23-copd-11-1161"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puhan</surname><given-names>MA</given-names></name><name><surname>Frey</surname><given-names>M</given-names></name><name><surname>B&#x000fc;chi</surname><given-names>S</given-names></name><name><surname>Sch&#x000fc;nemann</surname><given-names>HJ</given-names></name></person-group><article-title>The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease</article-title><source>Health Qual Life Outcomes</source><year>2008</year><volume>6</volume><fpage>46</fpage><pub-id pub-id-type="pmid">18597689</pub-id></element-citation></ref><ref id="b24-copd-11-1161"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Jones</surname><given-names>PW</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name></person-group><article-title>Minimum clinically important improvement for the incremental shuttle walking test</article-title><source>Thorax</source><year>2008</year><volume>63</volume><fpage>775</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">18390634</pub-id></element-citation></ref><ref id="b25-copd-11-1161"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepin</surname><given-names>V</given-names></name><name><surname>Laviolette</surname><given-names>L</given-names></name><name><surname>Brouillard</surname><given-names>C</given-names></name><etal/></person-group><article-title>Significance of changes in endurance shuttle walking performance</article-title><source>Thorax</source><year>2011</year><volume>66</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">21148135</pub-id></element-citation></ref><ref id="b26-copd-11-1161"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Institiute for Health and Clinical Excellence</collab></person-group><source>Chronic Obstructive Pulnmonary Disease Costing Report NICE Clinical Guidelines 101</source><publisher-loc>London</publisher-loc><publisher-name>National Institiute for Health and Clinical Excellence</publisher-name><year>2011</year></element-citation></ref><ref id="b27-copd-11-1161"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>TL</given-names></name><name><surname>Burr</surname><given-names>ML</given-names></name><name><surname>Campbell</surname><given-names>IA</given-names></name><etal/></person-group><article-title>Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial</article-title><source>Lancet</source><year>2000</year><volume>355</volume><issue>9201</issue><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">10665556</pub-id></element-citation></ref><ref id="b28-copd-11-1161"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodd</surname><given-names>JW</given-names></name><name><surname>Charlton</surname><given-names>RA</given-names></name><name><surname>van den Broek</surname><given-names>MD</given-names></name><name><surname>Jones</surname><given-names>PW</given-names></name></person-group><article-title>Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD</article-title><source>Chest</source><year>2013</year><volume>144</volume><issue>1</issue><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">23349026</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-copd-11-1161" position="float"><label>Figure 1</label><caption><p>CONSORT diagram.</p><p><bold>Abbreviations:</bold> SPACE, Self-management Program of Activity, Coping, and Education; PR, pulmonary rehabilitation; MRC, Medical Research Council; UHCW, University Hospitals Coventry and Warwickshire NHS Trust; UHL, University Hospitals of Leicester NHS Trust.</p></caption><graphic xlink:href="copd-11-1161Fig1"/></fig><fig id="f2-copd-11-1161" position="float"><label>Figure 2</label><caption><p>Kaplan&#x02013;Meier plots showing risk of respiratory readmission by randomization.</p><p><bold>Abbreviation:</bold> SPACE, Self-management Program of Activity, Coping, and Education.</p></caption><graphic xlink:href="copd-11-1161Fig2"/></fig><fig id="f3-copd-11-1161" position="float"><label>Figure 3</label><caption><p>Change in Chronic Respiratory Questionnaire &#x02013; self reported data from baseline to 3 months.</p><p><bold>Note:</bold> *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01, within group difference.</p><p><bold>Abbreviations:</bold> NS, not significant; SPACE, Self management Programme of Activity Coping and Education; CRQ, Chronic Respiratory Questionnaire.</p></caption><graphic xlink:href="copd-11-1161Fig3"/></fig><table-wrap id="t1-copd-11-1161" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the study population</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Characteristic</th><th valign="top" align="left" rowspan="1" colspan="1">Usual care</th><th valign="top" align="left" rowspan="1" colspan="1">SPACE for COPD</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex, male:female</td><td valign="top" align="left" rowspan="1" colspan="1">13:26</td><td valign="top" align="left" rowspan="1" colspan="1">15:24</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="left" rowspan="1" colspan="1">68.33 (7.73)</td><td valign="top" align="left" rowspan="1" colspan="1">67.64 (8.54)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub>, L</td><td valign="top" align="left" rowspan="1" colspan="1">0.95 (0.36)</td><td valign="top" align="left" rowspan="1" colspan="1">0.96 (0.45)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub>, %</td><td valign="top" align="left" rowspan="1" colspan="1">42.45 (11.73)</td><td valign="top" align="left" rowspan="1" colspan="1">40.47 (15.71)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub>/FVC ratio, %</td><td valign="top" align="left" rowspan="1" colspan="1">42.77 (10.54)</td><td valign="top" align="left" rowspan="1" colspan="1">47.09 (13.95)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Body mass index</td><td valign="top" align="left" rowspan="1" colspan="1">23.75 (5.61)</td><td valign="top" align="left" rowspan="1" colspan="1">25.49 (5.97)</td></tr><tr><td colspan="3" valign="top" align="left" rowspan="1">Smoking status (n)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Current:Ex:Never</td><td valign="top" align="left" rowspan="1" colspan="1">18:21:0</td><td valign="top" align="left" rowspan="1" colspan="1">14:24:1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Smoking pack years</td><td valign="top" align="left" rowspan="1" colspan="1">48.33 (29.02)</td><td valign="top" align="left" rowspan="1" colspan="1">52.39 (34.32)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease duration, years</td><td valign="top" align="left" rowspan="1" colspan="1">6.90 (5.99)</td><td valign="top" align="left" rowspan="1" colspan="1">7.89 (7.43)</td></tr><tr><td colspan="3" valign="top" align="left" rowspan="1">Marital status (n)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Married:partner:divorced: widowed:single</td><td valign="top" align="left" rowspan="1" colspan="1">12:2:11:12:2</td><td valign="top" align="left" rowspan="1" colspan="1">18:4:8:7:2</td></tr><tr><td colspan="3" valign="top" align="left" rowspan="1">Lives (n)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Alone:with partner:with family</td><td valign="top" align="left" rowspan="1" colspan="1">19:12:8</td><td valign="top" align="left" rowspan="1" colspan="1">14:17:8</td></tr><tr><td colspan="3" valign="top" align="left" rowspan="1">GOLD stage (n)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;I:II:III:IV</td><td valign="top" align="left" rowspan="1" colspan="1">0:10:12:12</td><td valign="top" align="left" rowspan="1" colspan="1">0:10:16:11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Medical Research Council dyspnea grade</td><td valign="top" align="left" rowspan="1" colspan="1">4 (3&#x02013;5)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (3&#x02013;5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;2:3:4:5 (n)</td><td valign="top" align="left" rowspan="1" colspan="1">6:5:13:15</td><td valign="top" align="left" rowspan="1" colspan="1">4:7:12:16</td></tr><tr><td colspan="3" valign="top" align="left" rowspan="1">Exercise history (n)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Current:previous:never</td><td valign="top" align="left" rowspan="1" colspan="1">6:22:11</td><td valign="top" align="left" rowspan="1" colspan="1">6:20:13</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-copd-11-1161"><p><bold>Note:</bold> Values are mean (SD) or median (interquartile range).</p></fn><fn id="tfn2-copd-11-1161"><p><bold>Abbreviations:</bold> SD, standard deviation; SPACE, Self-management Program of Activity, Coping, and Education; FEV<sub>1</sub>, forced expiratory volume in 1 second; FVC, forced vital capacity; GOLD, Global Initiative for chronic Obstructive Lung Disease.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-copd-11-1161" position="float"><label>Table 2</label><caption><p>Hospital length of stay (for readmission)</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Usual care</th><th valign="top" align="left" rowspan="1" colspan="1">SPACE for COPD</th><th valign="top" align="left" rowspan="1" colspan="1">Between-group difference</th></tr></thead><tbody><tr><td colspan="4" valign="top" align="left" rowspan="1">Intention-to-treat</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;All-cause</td><td valign="top" align="left" rowspan="1" colspan="1">16.5 (3.8&#x02013;39.8)</td><td valign="top" align="left" rowspan="1" colspan="1">9.0 (1.0&#x02013;30.0)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.218</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Respiratory</td><td valign="top" align="left" rowspan="1" colspan="1">15.0 (3.5&#x02013;32.0)</td><td valign="top" align="left" rowspan="1" colspan="1">12.0 (9.0&#x02013;33.8)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.341</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Nonrespiratory</td><td valign="top" align="left" rowspan="1" colspan="1">27.0 (7.5&#x02013;33.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 (1.0&#x02013;3.0)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.067</td></tr><tr><td colspan="4" valign="top" align="left" rowspan="1">Per protocol</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;All-cause</td><td valign="top" align="left" rowspan="1" colspan="1">13.0 (3.3&#x02013;25.5)</td><td valign="top" align="left" rowspan="1" colspan="1">9.0 (1.0&#x02013;27.8)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.381</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Respiratory</td><td valign="top" align="left" rowspan="1" colspan="1">11.0 (3.0&#x02013;21.0)</td><td valign="top" align="left" rowspan="1" colspan="1">11.0 (8.8&#x02013;37.5)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.597</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Nonrespiratory</td><td valign="top" align="left" rowspan="1" colspan="1">27.0 (7.5&#x02013;33.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 (0.8&#x02013;2.0)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.044</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-copd-11-1161"><p><bold>Note:</bold> Values are median (interquartile range) days.</p></fn><fn id="tfn3a-copd-11-1161"><p><bold>Abbreviation:</bold> SPACE, Self-management Program of Activity, Coping, and Education.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-copd-11-1161" position="float"><label>Table 3</label><caption><p>Baseline and change in secondary outcome measures at 3 months</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="top" align="left" rowspan="1">Usual care
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">SPACE for COPD
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1">Between-group difference</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Baseline</th><th valign="top" align="left" rowspan="1" colspan="1">Change</th><th valign="top" align="left" rowspan="1" colspan="1">Baseline</th><th valign="top" align="left" rowspan="1" colspan="1">Change</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-dyspnea</td><td valign="top" align="left" rowspan="1" colspan="1">2.22 (0.95)</td><td valign="top" align="left" rowspan="1" colspan="1">0.45 (1.17)<xref ref-type="table-fn" rid="tfn5-copd-11-1161">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">2.36 (0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">1.05 (1.26)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.062</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-fatigue</td><td valign="top" align="left" rowspan="1" colspan="1">2.40 (0.97)</td><td valign="top" align="left" rowspan="1" colspan="1">0.62 (1.21)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1">2.23 (1.08)</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (1.22)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.245</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-emotion</td><td valign="top" align="left" rowspan="1" colspan="1">3.41 (1.29)</td><td valign="top" align="left" rowspan="1" colspan="1">0.37 (1.60)</td><td valign="top" align="left" rowspan="1" colspan="1">3.12 (0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">1.09 (1.51)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.077</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-mastery</td><td valign="top" align="left" rowspan="1" colspan="1">3.24 (1.36)</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (1.51)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1">2.81 (1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">1.41 (1.48)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.181</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ISWT (m)</td><td valign="top" align="left" rowspan="1" colspan="1">60 (10&#x02013;167.50)</td><td valign="top" align="left" rowspan="1" colspan="1">30 (0&#x02013;95)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1">60 (30&#x02013;150)</td><td valign="top" align="left" rowspan="1" colspan="1">45 (0&#x02013;70)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.769</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ESWT (seconds)</td><td valign="top" align="left" rowspan="1" colspan="1">50 (0&#x02013;171)</td><td valign="top" align="left" rowspan="1" colspan="1">155 (21&#x02013;618.50)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1">110 (8&#x02013;196.50)</td><td valign="top" align="left" rowspan="1" colspan="1">178.5 (&#x02212;3.75 to 443.50)<xref ref-type="table-fn" rid="tfn6-copd-11-1161">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.951</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HADS-anxiety</td><td valign="top" align="left" rowspan="1" colspan="1">7.79 (3.84)</td><td valign="top" align="left" rowspan="1" colspan="1">0.28 (3.48)</td><td valign="top" align="left" rowspan="1" colspan="1">9.62 (4.33)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.27 (3.45)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.563</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HADS-depression</td><td valign="top" align="left" rowspan="1" colspan="1">7.18 (3.18)</td><td valign="top" align="left" rowspan="1" colspan="1">0.76 (4.30)</td><td valign="top" align="left" rowspan="1" colspan="1">6.97 (4.18)</td><td valign="top" align="left" rowspan="1" colspan="1">0.54 (3.29)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.833</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PRAISE</td><td valign="top" align="left" rowspan="1" colspan="1">39.08 (9.40)</td><td valign="top" align="left" rowspan="1" colspan="1">2.34 (8.73)</td><td valign="top" align="left" rowspan="1" colspan="1">40.15 (7.73)</td><td valign="top" align="left" rowspan="1" colspan="1">0.54 (9.48)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.465</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BCKQ</td><td valign="top" align="left" rowspan="1" colspan="1">31.71 (9.21)</td><td valign="top" align="left" rowspan="1" colspan="1">2.10 (7.19)</td><td valign="top" align="left" rowspan="1" colspan="1">33.90 (8.38)</td><td valign="top" align="left" rowspan="1" colspan="1">3.92 (7.14)<xref ref-type="table-fn" rid="tfn5-copd-11-1161">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.364</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-copd-11-1161"><p><bold>Notes:</bold> Mean (SD) or median (IQR) are reported as appropriate.</p></fn><fn id="tfn5-copd-11-1161"><label>*</label><p><italic>P</italic>&#x0003c;0.05 within-group difference,</p></fn><fn id="tfn6-copd-11-1161"><label>**</label><p><italic>P</italic>&#x0003c;0.01 within-group difference.</p></fn><fn id="tfn7-copd-11-1161"><p><bold>Abbreviations:</bold> SD, standard deviation; IQR, interquartile range; SPACE, Self-management Program of Activity, Coping, and Education; CRQ, Chronic Respiratory Questionnaire; ISWT, Incremental Shuttle Walk Test; ESWT, Endurance Shuttle Walk Test; HADS, Hospital Anxiety and Depression Scale; PRAISE, Pulmonary Rehabilitation Adapted Index of Self-Efficacy; BCKQ, Bristol COPD Knowledge Questionnaire.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-copd-11-1161" position="float"><label>Table 4</label><caption><p>Number (%) of participants who achieved the MCID</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Usual care</th><th valign="top" align="left" rowspan="1" colspan="1">SPACE for COPD</th><th valign="top" align="left" rowspan="1" colspan="1">Between-group difference</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-dyspnea</td><td valign="top" align="left" rowspan="1" colspan="1">11 (36.67%)</td><td valign="top" align="left" rowspan="1" colspan="1">19 (63.33%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.039<xref ref-type="table-fn" rid="tfn8-copd-11-1161">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-fatigue</td><td valign="top" align="left" rowspan="1" colspan="1">17 (56.67%)</td><td valign="top" align="left" rowspan="1" colspan="1">23 (76.67%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.104</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-emotion</td><td valign="top" align="left" rowspan="1" colspan="1">17 (56.67%)</td><td valign="top" align="left" rowspan="1" colspan="1">19 (63.33%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.605</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRQ-mastery</td><td valign="top" align="left" rowspan="1" colspan="1">22 (73.33%)</td><td valign="top" align="left" rowspan="1" colspan="1">22 (73.33%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ISWT</td><td valign="top" align="left" rowspan="1" colspan="1">9 (42.86%)</td><td valign="top" align="left" rowspan="1" colspan="1">11 (50%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.648</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ESWT</td><td valign="top" align="left" rowspan="1" colspan="1">8 (47.06%)</td><td valign="top" align="left" rowspan="1" colspan="1">10 (50%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.863</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HADS-anxiety</td><td valign="top" align="left" rowspan="1" colspan="1">5 (17.24%)</td><td valign="top" align="left" rowspan="1" colspan="1">9 (34.62%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.151</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HADS-depression</td><td valign="top" align="left" rowspan="1" colspan="1">10 (34.48%)</td><td valign="top" align="left" rowspan="1" colspan="1">8 (30.77%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.775</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold></p></fn><fn id="tfn8-copd-11-1161"><label>*</label><p><italic>P</italic>&#x0003c;0.05.</p></fn><fn id="tfn9-copd-11-1161"><p><bold>Abbreviations:</bold> MCID, minimal clinically important difference; CRQ, Chronic Respiratory Questionnaire; ISWT, Incremental Shuttle Walk Test; ESWT, Endurance Shuttle Walk Test; HADS, Hospital Anxiety and Depression Scale; SPACE, Self management Programme of Activity Coping and Education.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-copd-11-1161" position="float"><label>Table 5</label><caption><p>How people feel upon discharge from hospital following treatment for their COPD (% per group)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="top" align="left" rowspan="1">Very
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Fairly
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Neither yes or no
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Not really
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Not at all
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Don&#x02019;t know
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1">Between-group differences</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SM</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SM</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SM</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SM</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SM</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SM</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Ready (well enough) to leave hospital</td><td valign="top" align="left" rowspan="1" colspan="1">39</td><td valign="top" align="left" rowspan="1" colspan="1">43</td><td valign="top" align="left" rowspan="1" colspan="1">39</td><td valign="top" align="left" rowspan="1" colspan="1">33</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.976</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Reassured about being able to cope at home</td><td valign="top" align="left" rowspan="1" colspan="1">36</td><td valign="top" align="left" rowspan="1" colspan="1">53</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">21</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.230</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Informed about your COPD and reasons for admission</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">47</td><td valign="top" align="left" rowspan="1" colspan="1">21</td><td valign="top" align="left" rowspan="1" colspan="1">27</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.086</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Confident about how/when to take medications</td><td valign="top" align="left" rowspan="1" colspan="1">68</td><td valign="top" align="left" rowspan="1" colspan="1">70</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.444</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Confident that COPD medications could help</td><td valign="top" align="left" rowspan="1" colspan="1">46</td><td valign="top" align="left" rowspan="1" colspan="1">67</td><td valign="top" align="left" rowspan="1" colspan="1">36</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.049<xref ref-type="table-fn" rid="tfn11-copd-11-1161">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Reassured that good support was available at home</td><td valign="top" align="left" rowspan="1" colspan="1">46</td><td valign="top" align="left" rowspan="1" colspan="1">67</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.022<xref ref-type="table-fn" rid="tfn11-copd-11-1161">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Positive about the future</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">27</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">43</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">17</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.156</td></tr></tbody></table><table-wrap-foot><fn id="tfn10-copd-11-1161"><p><bold>Notes:</bold> Not all participants completed each question; therefore, not all scores total 100%.</p></fn><fn id="tfn11-copd-11-1161"><label>*</label><p><italic>P</italic>&#x0003c;0.05.</p></fn><fn id="tfn12-copd-11-1161"><p><bold>Abbreviations:</bold> UC, usual care; SM, self-management (Self management Programme of Activity, Coping and Education (SPACE)).</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6-copd-11-1161" position="float"><label>Table 6</label><caption><p>Effect of (baseline) hospitalization on how people felt they changed and consequently managed their COPD (%)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="top" align="left" rowspan="1">Increased/better/more often
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">No change
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Reduced/worsened/less often
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1">Between-group difference</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SPACE for COPD</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SPACE for COPD</th><th valign="top" align="left" rowspan="1" colspan="1">UC</th><th valign="top" align="left" rowspan="1" colspan="1">SPACE for COPD</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Your level of exercise and general activities</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">37</td><td valign="top" align="left" rowspan="1" colspan="1">57</td><td valign="top" align="left" rowspan="1" colspan="1">43</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.097</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Your ability to arrange your life to cope with COPD</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">50</td><td valign="top" align="left" rowspan="1" colspan="1">79</td><td valign="top" align="left" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.012<xref ref-type="table-fn" rid="tfn14-copd-11-1161">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Taking your medications on time as prescribed</td><td valign="top" align="left" rowspan="1" colspan="1">17</td><td valign="top" align="left" rowspan="1" colspan="1">57</td><td valign="top" align="left" rowspan="1" colspan="1">71</td><td valign="top" align="left" rowspan="1" colspan="1">43</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.017<xref ref-type="table-fn" rid="tfn14-copd-11-1161">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Knowing when to seek help about feeling unwell</td><td valign="top" align="left" rowspan="1" colspan="1">43</td><td valign="top" align="left" rowspan="1" colspan="1">73</td><td valign="top" align="left" rowspan="1" colspan="1">57</td><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.038<xref ref-type="table-fn" rid="tfn14-copd-11-1161">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Your efforts to give up/avoid smoking</td><td valign="top" align="left" rowspan="1" colspan="1">36</td><td valign="top" align="left" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">46</td><td valign="top" align="left" rowspan="1" colspan="1">37</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.438</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Your participation in discussion forums/groups</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">75</td><td valign="top" align="left" rowspan="1" colspan="1">67</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.161</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">The use of available community support services</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">82</td><td valign="top" align="left" rowspan="1" colspan="1">60</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>=0.058</td></tr></tbody></table><table-wrap-foot><fn id="tfn13-copd-11-1161"><p><bold>Notes:</bold> Not all participants completed each question; therefore, not all scores total 100%.</p></fn><fn id="tfn14-copd-11-1161"><label>*</label><p><italic>P</italic>&#x0003c;0.05.</p></fn><fn id="tfn15-copd-11-1161"><p><bold>Abbreviations:</bold> UC, usual care; SPACE, Self-management Program of Activity, Coping, and Education.</p></fn></table-wrap-foot></table-wrap></floats-group></article>